The U.S. surgical sutures market was valued at approximately USD 1.89 billion in 2025 and is anticipated to grow to USD 2.21 billion by 2030, registering a compound annual growth rate (CAGR) of 3.18% between 2025 and 2030. Growth is driven by increasing surgical procedures, including both elective and emergency surgeries, alongside expanding adoption of minimally invasive techniques.

The U.S. orthodontic headgear market was valued at approximately USD 368.43 million in 2024 and is projected to reach USD 591.80 million by 2033, growing at a compound annual growth rate (CAGR) of 5.46% from 2025 to 2033.

The Australia & New Zealand healthcare contract research organizations (CROs) market was valued at approximately USD 1.45 billion in 2025 and is projected to reach USD 3.35 billion by 2033, expanding at a compound annual growth rate (CAGR) of 11.02% from 2025 to 2033. Market growth is supported by strong regulatory and ethical frameworks, government incentives, investment in research and development (R&D), advanced infrastructure, and a diverse patient population.

The global hemorrhoids treatment market was valued at approximately USD 818.82 million in 2025 and is expected to reach USD 1,465.28 million by 2033, growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2033. The market growth is driven by the increasing prevalence of hemorrhoidal disorders, influenced by sedentary lifestyles, poor dietary habits, rising obesity levels, and aging populations leading to reduced tissue elasticity.

The global beef cattle health market was valued at approximately USD 6.23 billion in 2025 and is projected to reach USD 12.22 billion by 2033, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2033. Market growth is driven by the rising incidence of infectious and parasitic diseases such as bovine respiratory disease and New World screwworm, which adversely affect herd productivity and cattle health.

The global acute pancreatitis market was valued at approximately USD 3.57 billion in 2025 and is anticipated to grow to USD 5.60 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.8% from 2025 to 2033. The market expansion is driven by increased awareness of pancreatic health, a rising incidence of lifestyle-related disorders, and advancements in diagnostic and therapeutic technologies.

The global market for thyroid support supplements was valued at approximately USD 2.00 billion in 2025 and is anticipated to grow to USD 4.08 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9.29% between 2025 and 2033. Consumer interest is increasingly focused on natural and herbal supplements containing ingredients like iodine, selenium, zinc, ashwagandha, and vitamin B12 to support thyroid function and metabolic balance.

The global corporate wellness market was valued at approximately USD 55.10 billion in 2025 and is expected to grow to USD 63.90 billion by 2030, expanding at a compound annual growth rate (CAGR) of around 3.01% during 2025 to 2030. Increasing awareness surrounding employee health and well-being is a pivotal factor fueling this market’s development.

The global coronary artery bypass graft (CABG) market was valued at approximately USD 20.43 billion in 2025 and is expected to reach USD 27.66 billion by 2033, with a compound annual growth rate (CAGR) of about 3.86% from 2025 to 2033. The increasing prevalence of cardiovascular diseases worldwide is a primary factor stimulating market expansion.

The global surgical sutures market was valued at approximately USD 5.02 billion in 2025 and projected to reach USD 6.46 billion by 2030, reflecting a compound annual growth rate (CAGR) of 5.2% during the forecast period. Market growth is fueled by increasing surgical procedures globally and innovations in suture materials, including smart and antibacterial sutures.